Health News & Press Release Distribution

Health

APAC
Global

Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatment SINGAPORE, June 29, 2023 /PRNewswire/ -- Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced the of...

2023-06-29 17:14 3504

Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

Berlin Heals Holding AG Successfully Completes Financing Round for Ongoing CE-Study

ZUG, Switzerland, June 29, 2023 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech startup, has developed a breakthrough method and a product for the therapy of heart failure. The product - an electronic device called C-MIC - has already successfully been tested in patients in a pilot study and i...

2023-06-29 17:00 2393

Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer

BEIJING, KYOTO and BOSTON, June 29, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced clinical results of its novel KRAS G12C inhibitor glecirasib monotherapy and in combination therapy with cetuximab to treat KRAS G...

2023-06-29 16:31 1875

Lenzing signs strategic partnership with NBond to accelerate the innovation of flushable nonwovens products globally

* NBond has been a long-term user of Lenzing's VEOCEL™ branded fibers in nonwoven products, and the first to incorporate VEOCEL™ branded lyocell shortcut fibers in flushable feminine care products globally * The new strategic partnership will enable both parties to explore new possibilities f...

2023-06-29 11:15 2921

Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective

TB is one of the world's deadliest diseases, killing about 4,300 people per day, mostly those living in poverty LONDON and SEATTLE, June 29, 2023 /PRNewswire/ -- Wellcome and the Bill & Melinda Gates Foundation today announced funding to advance a tuberculosis (TB) vaccine candidate, M72/AS01E ...

2023-06-29 00:00 2901

Clarity establishes a US Center of Excellence for Targeted Copper Theranostics

SYDNEY, June 28, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the establishment of a ...

2023-06-28 20:58 2322

Flat Medical Expands Leadership Team to Manage Growth in Europe and the United States

TAIPEI, June 28, 2023 /PRNewswire/ -- Flat Medical Co. Ltd., a leading MedTech company specializing in safety solutions for anesthesia and critical care, is pleased to announce the appointment of two executives who will spearhead the company's expansion inEurope and America. Jan Wormmeester has b...

2023-06-28 20:30 1821

Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development

SHANGHAI, June 28, 2023 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as Sanyou) and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963) (hereinafter referred to asHuadong Medicine), signed...

2023-06-28 20:00 1916

Babies Bliss Introduces Comprehensive Fertility Wellness Programme to Enhance Reproductive Health and Conception Journey

SINGAPORE, June 28, 2023 /PRNewswire/ -- Babies Bliss, a Singapore-based fertility wellness centre, is proud to announce its innovative fertility wellness programme designed to support women in improving their reproductive health and preparing their bodies for conception. The comprehensive progra...

2023-06-28 18:44 2175

Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite

* CBL-514 is the only non-invasive product that can improve 1-level of cellulite severity two weeks after a single treatment. * The highest dose of CBL-514 treatment demonstrated the best efficacy, 87.5% of thighs achieved at least 1-level improvement in cellulite severity two weeks after CBL...

2023-06-28 18:30 1861

Quhuo Creates a Warm and Supportive Work Environment for Deaf-Mute Riders

BEIJING, June 28, 2023 /PRNewswire/ -- "I joined Quhuo as a delivery rider in 2020 and have been working for three years now, and joining Quhuo has been a great blessing for me." Zhang Xueqing expresses immense gratitude for becoming a delivery rider forQuhuo Limited

2023-06-28 18:00 2156

European Society of Hypertension Announces Comprehensive New Guidelines for the Management of Arterial Hypertension

MILAN, June 28, 2023 /PRNewswire/ -- The European Society of Hypertension (ESH), the leading hypertension society inEurope, released updated and expanded 2023 ESH Guidelines for the Management of Arterial Hypertension during three oral presentations atthe 32nd Annual European Meeting on Hypertens...

2023-06-28 18:00 7143

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

COPENHAGEN, Denmark, June 28, 2023 /PRNewswire/ -- The Society of Human Reproduction and Embryology (ESHRE) annual meeting witnessed a historic event as people from around the globe gathered both in person and online to set a new world record for the most people consuming a dose of inositol simul...

2023-06-28 17:25 2464

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

Nuance Pharma's Partner Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD

SHANGHAI, June 28, 2023 /PRNewswire/ -- Nuance Pharma announces its partner, Verona Pharma plc (Nasdaq: VRNA), has submitted a New Drug Application ("NDA") to the US Food and Drug Administration ("FDA") for approval of ensifentrine for the maintenance treatment of patients with chronic obstructi...

2023-06-28 17:07 3337

DigiconAsia readers recognize Asia's vertical industry innovation providers

The 2023 DigiconAsia DX Solution Excellence Awards honors APAC's digital innovators for providing transformative solutions and services across various industry sectors. SINGAPORE, June 28, 2023 /PRNewswire/ -- In the midst of a tum...

2023-06-28 13:00 2492

DigiconAsia readers recognize Asia's vertical industry innovation providers

CLÉ DE PEAU BEAUTÉ CELEBRATES THE SCIENCE OF SKIN INTELLIGENCE

Clé de Peau Beauté's revolutionary skincare science, experienced in a global three-day event that also premières immersive AI art installation "Unseen Intelligence" byRefik Anadol TOKYO, June 28, 2023 /PRNewswire/ -- Clé de Peau Beauté, the SHISEIDO Group's global luxury skincare and makeup br...

2023-06-28 10:00 3032

CLÉ DE PEAU BEAUTÉ CELEBRATES THE SCIENCE OF SKIN INTELLIGENCE

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA

HONG KONG, June 27, 2023 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltdtogether with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd. ("Xuanzhu Biopharm"), a non-wholly owned subsidiary of Company, has received a drug registration approval from the Natio...

2023-06-28 09:57 1903

Besrey Heralds New Era of "Modern Scientific Parenting" with Complete Product Line, Innovations

HAMBURG, Germany, June 28, 2023 /PRNewswire/ -- Besrey , which provides families around the world with high-quality baby products, has announced its complete transition into the new era of "Modern Scientific Parenting," with four major product categories and plans to cent...

2023-06-28 09:00 2145

LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma

MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investigation showed patients treated with MINJUVI had prolonged, durable responses[2] SINGAPORE, June 27, 2023 /PRNewswire/ -- Independent biopharmaceutical ...

2023-06-28 04:00 1880

Momcozy Answers Challenges of Modern Motherhood with Thoughtfully Designed Products at Great Prices

NEW YORK, June 27, 2023 /PRNewswire/ -- Momcozy, the renowned maternity and baby brand endorsed by over two million moms globally, is excited to announcei ts official website is offering the exclu...

2023-06-27 23:00 1830

Momcozy Answers Challenges of Modern Motherhood with Thoughtfully Designed Products at Great Prices

1 ... 227 228 229230231 232 233 ... 858